ATC groups

Anatomicko-terapeuticko-chemické skupiny jsou definovány Světovou zdravotnickou organizací, viz www.whocc.no.

± A: ALIMENTARY TRACT AND METABOLISM

± A01: STOMATOLOGICAL PREPARATIONS

± A02: DRUGS FOR ACID RELATED DISORDERS

± A03: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS

± A04: ANTIEMETICS AND ANTINAUSEANTS

± A05: BILE AND LIVER THERAPY

± A06: DRUGS FOR CONSTIPATION

± A07: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS

± A08: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS

± A09: DIGESTIVES, INCL. ENZYMES

± A10: DRUGS USED IN DIABETES

± A10A: INSULINS AND ANALOGUES

± A10B: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS

± A10BA: BIGUANIDES

± A10BB: SULFONYLUREAS

± A10BC: SULFONAMIDES (HETEROCYCLIC)

± A10BD: COMBINATIONS OF ORAL BLOOD GLUCOSE LOWERING DRUGS

A10BD01: PHENFORMIN AND SULFONYLUREAS

A10BD02: METFORMIN AND SULFONYLUREAS

A10BD03: METFORMIN AND ROSIGLITAZONE

A10BD04: GLIMEPIRIDE AND ROSIGLITAZONE

A10BD05: METFORMIN AND PIOGLITAZONE

A10BD06: GLIMEPIRIDE AND PIOGLITAZONE

A10BD07: METFORMIN AND SITAGLIPTIN

A10BD08: METFORMIN AND VILDAGLIPTIN

A10BD09: PIOGLITAZONE AND ALOGLIPTIN

A10BD10: METFORMIN AND SAXAGLIPTIN

A10BD11: METFORMIN AND LINAGLIPTIN

A10BD12: PIOGLITAZONE AND SITAGLIPTIN

A10BD13: METFORMIN AND ALOGLIPTIN

A10BD14: METFORMIN AND REPAGLINIDE

A10BD15: METFORMIN AND DAPAGLIFLOZIN

A10BD16: METFORMIN AND CANAGLIFLOZIN

A10BD17: METFORMIN AND ACARBOSE

A10BD18: METFORMIN AND GEMIGLIPTIN

A10BD19: LINAGLIPTIN AND EMPAGLIFLOZIN

A10BD20: METFORMIN AND EMPAGLIFLOZIN

A10BD21: SAXAGLIPTIN AND DAPAGLIFLOZIN

A10BD22: METFORMIN AND EVOGLIPTIN

A10BD23: METFORMIN AND ERTUGLIFLOZIN

A10BD24: SITAGLIPTIN AND ERTUGLIFLOZIN

A10BD25: METFORMIN, SAXAGLIPTIN AND DAPAGLIFLOZIN

A10BD26: METFORMIN AND LOBEGLITAZONE

A10BD27: METFORMIN, LINAGLIPTIN AND EMPAGLIFLOZIN

± A10BF: ALPHA GLUCOSIDASE INHIBITORS

± A10BG: THIAZOLIDINEDIONES

± A10BH: DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS

± A10BJ: GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES

± A10BK: SODIUM-GLUCOSE CO-TRANSPORTER 2 (SGLT2) INHIBITORS

± A10BX: OTHER BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS

± A10X: OTHER DRUGS USED IN DIABETES

± A11: VITAMINS

± A12: MINERAL SUPPLEMENTS

± A13: TONICS

± A14: ANABOLIC AGENTS FOR SYSTEMIC USE

A15: APPETITE STIMULANTS

± A16: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS

± B: BLOOD AND BLOOD FORMING ORGANS

± C: CARDIOVASCULAR SYSTEM

± D: DERMATOLOGICALS

± G: GENITO URINARY SYSTEM AND SEX HORMONES

± H: SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS

± J: ANTIINFECTIVES FOR SYSTEMIC USE

± L: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

± M: MUSCULO-SKELETAL SYSTEM

± N: NERVOUS SYSTEM

± P: ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

± R: RESPIRATORY SYSTEM

± S: SENSORY ORGANS

± V: VARIOUS